[1]姚玲玲,王家宁,黄永章,等.pET15b-PEP-1-CAT原核表达质粒的构建及PEP-1-CAT融合蛋白的表达与纯化[J].南方医科大学学报,2006,(09):1319-1325.
 YAO Ling-ling,WANG Jia-ning,HUANG Yong-zhang,et al.Construction of prokaryotic expression plasmid pET15b-PEP-1-CAT and expression and purification of PEP-1-CAT fusion protein[J].,2006,(09):1319-1325.
点击复制

pET15b-PEP-1-CAT原核表达质粒的构建及PEP-1-CAT融合蛋白的表达与纯化()
分享到:

《南方医科大学学报》[ISSN:/CN:]

卷:
期数:
2006年09期
页码:
1319-1325
栏目:
论著·基础研究
出版日期:
2000-01-01

文章信息/Info

Title:
Construction of prokaryotic expression plasmid pET15b-PEP-1-CAT and expression and purification of PEP-1-CAT fusion protein
作者:
姚玲玲; 王家宁; 黄永章; 郭凌郧;
郧阳医学院附属人民医院临床医学研究所; 郧阳医学院附属人民医院临床医学研究所 湖北十堰442000; 湖北十堰442000;
Author(s):
YAO Ling-ling WANG Jia-ning HUANG Yong-zhang GUO Ling-yun Institute of Clinical Medicine People’s Hospital Yunyang Medical College Shiyan 442000 China
关键词:
原核表达 过氧化氢酶 TA克隆 同尾酶 融合蛋白
Keywords:
prokaryotic expression catalase TA-cloning isocaudarner fusion protein
分类号:
R346
摘要:
目的构建pET15b-PEP-1-CAT原核表达质粒,并表达、纯化得到融合蛋白PEP-1-CAT,为防治与氧化应激有关的疾病奠定基础。方法设计并合成两端分别带SalI和BglII酶切位点的CAT引物,用PCR方法以pZeoSV2(+)-CAT质粒为模板,特异性扩增CAT全长cDNA。将扩增的CATcDNA与dATP反应,利用TaqDNA聚合酶具有的非模板依赖性末端转移酶活性在CATcDNA的3’末端加“A”并纯化,然后应用TA克隆策略将纯化后的CATcDNA插入至中间载体pGEM-TEasyVector中得到pGEM-T-CAT。人工合成编码PEP-1的双链寡核苷酸,两端分别引入NdeI和XhoI酶切位点,将其插入pET15b中得到重组质粒pET15b-PEP-1。pGEM-T-CAT和pET15b-PEP-1分别经SalI-BglII和XhoI-BamHI双酶切,利用同尾酶(SalI与XhoI,BglII与BamHI)能酶切产生相同黏性末端的特性,将回收得到的CATcDNA片段与pET15b-PEP-1相连,构建出重组质粒pET15b-PEP-1-CAT,经PCR及酶切鉴定,并通过核苷酸序列测序证实。将鉴定正确的pET15b-PEP-1-CAT重组质粒转化BL21(DE3),用IPTG诱导目的蛋白表达。然后利用重组蛋白N端的组氨酸“标签”(His-tag)对其进行金属螯合亲和层析纯化。结果测序分析证实,克隆入pET15b的PEP-1序列与设计合成的PEP-1序列一致,CAT序列与GeneBank中登录号为“AY028632”的CATcDNA序列一致。SDS-PAGE和Westernblot结果表明,pET15b-PEP-1-CAT在E.coli中获得可溶性高表达,经Ni2+-NTA-树脂柱亲和层析纯化得到了PAGE纯的融合蛋白PEP-1-CAT,并在体外检测到其具有特异的过氧化氢酶活性,活性值为77.15U/g。结论成功构建了原核表达载体pET15b-PEP-1-CAT,并经表达、纯化得到可以天然活性形式穿透细胞的重组过氧化氢酶蛋白,从而为防治心肌缺血再灌注损伤等与氧化应激有关的疾病奠定了基础。
Abstract:
Objective To construct the prokaryotic expression plasmid pET15b-PEP-1-CAT to obtain purified fusion protein of PEP-1-CAT. Methods Using pfu DNA polymerase, the full-length human catalase cDNA was amplified by PCR from pZeoSV2(+)-CAT plasmid, and the PCR product was added with "A" using Taq DNA polymerase. The purified product of CAT cDNA with the base A at its 3’ end was ligated with pGEM-T Easy vector and transformed into DH5α. The correct recombinant was identified by PCR and SalⅠ/BglⅡ digestion and named as pGEM-T-CAT. Two oligoncleotides were synthesized and annealed to generate a double-stranded oligonucleotide encoding the PEP-1 peptide, which was directly ligated into Nde I/Xho I-digested pET15b.The recombinant plasmid was identified by double-enzyme digestion and named as pET15b-PEP-1. pET15b-PEP-1 and pGEM-T-CAT were further digested by Xho I/BamH I and Sal I/BglⅡ, respectively. The purified linear fragment of pET15b-PEP-1 and CAT cDNA fragment were ligated using two pairs of isocaudarners possessing different recognition sequences but producing compatible cohesive ends. The clone with the expected insert was selected using Xho I restriction analysis followed by sequence analysis. The recombinant plasmid was transformed into E.coli BL21(DE3) which was induced by IPTG. The recombinant protein possessed an N-terminal His-tag sequence which could be used to purify the target protein by affinity chromatography on a Ni2+-NTA-resin column. The fusion protein PEP-1-CAT was produced and confirmed by specific enzyme activity in vitro. Results Sequence analysis showed that the PEP-1 and the human CAT cDNA sequence of pET15b- PEP-1-CAT had identical sequence with designed PEP-1 peptide and human catalase cDNA sequence in GenBank (accession No. AY028632), respectively. SDS-PAGE and Western blotting confirmed successful expression and purification of PEP-1-CAT fusion protein with specific activity of 77.15 U/g. Conclusion The prokaryotic expression plasmid pET15b-PEP-1-CAT has been constructed successfully, and the successful expression and purification of PEP-1-CAT provides a basis for prevention and therapy of various disorders related to oxidative stress.?

相似文献/References:

[1]刘影,姜玉新,李朝品.黄粉虫抗菌肽Tenecin基因的克隆、原核表达及其抑菌活性[J].南方医科大学学报,2011,(12):2002.
[2]曾建明,刘飞,谭坪海,等.人CD96基因胞外区的原核表达及抗血清制备[J].南方医科大学学报,2011,(07):1232.
[3]宋远斌,余楠,何思杰,等.肠道病毒71型VP1~VP4基因克隆及其表达产物的免疫原性[J].南方医科大学学报,2011,(11):1846.
[4]孙海涛,杨化强,杨璐军,等.人Tau基因多表位肽段原核表达载体的构建与表达[J].南方医科大学学报,2012,(02):185.
[5]董金凯,罗津,阎瑾琦,等.小鼠前列腺干细胞抗原的原核表达、纯化及抗原活性检测[J].南方医科大学学报,2012,(04):502.
[6]赵善超,姜勇,刘靖华,等.人可溶性晚期糖基化终产物受体的原核表达及活性鉴定[J].南方医科大学学报,2005,(07):769.
 ZHAO Shan-chao,JIANG Yong,LIU Jing-hua,et al.Prokaryotic expression and activity identification of recombinant human soluble receptor for advanced glycation end products[J].,2005,(09):769.
[7]宋远斌,何思杰,余楠,等.柯萨奇病毒A16型VP1~VP4基因克隆及其表达产物的抗原相关性分析[J].南方医科大学学报,2012,(12):1713.
[8]任瑞文,唐博恒,张培,等.登革2型病毒特异性抗原片段的筛选及验证[J].南方医科大学学报,2012,(11):1667.
[9]王伟,殷小涛,李云奇,等.小鼠VEGFR2胞外1-4IgG样结构域的原核表达、纯化及活性鉴定[J].南方医科大学学报,2013,(01):13.
[10]刘闻,吴丽红,徐名衬,等.免疫瘦素受体胞外近跨膜区重组融合蛋白对SD大鼠脂肪沉积的影响[J].南方医科大学学报,2013,(06):832.

更新日期/Last Update: 1900-01-01